Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-042401)

Filing Details

Accession Number:: 0001209191-19-042401
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-17 16:52:30
Reporting Period:: 2019-07-15

Accepted Time:: 2019-07-17 16:52:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662524	Akcea Therapeutics Inc.	AKCA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1629383	Sarah Boyce	C/O Akcea Therapeutics, Inc. 22 Boston Wharf Road, 9Th Floor Boston MA 02210	President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-07-15	1,819	$23.52	19,888	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on April 17, 2018.